<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339013</id>
  <title nil="true"/>
  <common-name>2-[2-(1,3-benzodioxol-5-yl)-6-[4-(morpholine-4-carbonyl)anilino]pyrimidin-4-yl]-n-hydroxyacetamide</common-name>
  <description>2-[2-(1,3-benzodioxol-5-yl)-6-[4-(morpholine-4-carbonyl)anilino]pyrimidin-4-yl]-n-hydroxyacetamide is a chemical compound with the formula C24H23N5O6. It has an average molecular weight of 477.50 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>3044726</pubchem-id>
  <chemical-formula>C24H23N5O6</chemical-formula>
  <weight>477.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T22:12:38Z</created-at>
  <updated-at type="dateTime">2026-08-30T22:12:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1COCCN1C(=O)C2=CC=C(C=C2)NC3=NC(=NC(=C3)CC(=O)NO)C4=CC5=C(C=C4)OCO5</moldb-smiles>
  <moldb-formula>C24H23N5O6</moldb-formula>
  <moldb-inchi>InChI=1S/C24H23N5O6/c30-22(28-32)13-18-12-21(27-23(26-18)16-3-6-19-20(11-16)35-14-34-19)25-17-4-1-15(2-5-17)24(31)29-7-9-33-10-8-29/h1-6,11-12,32H,7-10,13-14H2,(H,28,30)(H,25,26,27)</moldb-inchi>
  <moldb-inchikey>PYGZZUNWTNNBGI-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">477.1648335</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>1.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM334906</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[2-(1,3-benzodioxol-5-yl)-6-[4-(morpholine-4-carbonyl)anilino]pyrimidin-4-yl]-n-hydroxyacetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzodioxoles</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289439</sync-id>
  <structure-inchikey>PYGZZUNWTNNBGI-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>100000004000000000800000000000000000008000000100001000000000000000000000000000040000000000002000000000000000400000000000104000001000000000000000000000000000000020800000000000000008002000000000000000010000000010000000120000800000020102021000000000000000000010020001000000001000000000000080800000000000000000800400000000000002010000000004000000084000040000000040000000008000008100080000000000000000080000001100010000000000004000000000000200000000000280000000000001010040000000400400000000000000000000004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:37Z</structure-indexed-at>
</compound>
